Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / revised-lcd-moldx-strategy-memo.docx
revised-lcd-moldx-strategy-memo.docx
Parties
HARKNESS LLP
Genome Dx Therapeutics Inc
Sable LLP
Dates
April 9, 2024
March 29, 2024
April 15, 2024
December 14, 2022
February 14, 2024
June 28, 2024
March 11, 2024
March 22, 2024
April 5, 2024
April 30, 2024
Amounts
$3,850
$28,500,000
$19,100,000
$9,400,000
$3,622.33
$4,206
$20,290,500
$34,502,500
$34,000,000
$6,200,000
Obligations
The prospective clinical validation study is the linchpin of the coverage case, and the coverage strategy must be aligned with the availability of mature data from that study